Small intestine causes chronic inflammation in obese patients

Obesity is caused by numerous and complex factors, some of which are as yet unsuspected. Scientists from the CNRS, INSERM, UPMC and Université Paris Descartes, working with research clinicians from Paris Public Hospitals (AP-HP) have now shown that severe obesity is accompanied by inflammation of the small intestine and enhanced immune response in that region. This phenomenon reduces the insulin sensitivity of enterocytes and increases the absorption of nutrients, thus exacerbating the disease. This work, carried out at the Centre de Recherche des Cordeliers (INSERM/UPMC/Université Paris Descartes) and the Institut de Cardiométabolisme et Nutrition (ICAN - INSERM/UPMC/AP-HP), is published on 18 June in Cell Metabolism.

Study of the mechanisms involved in human obesity is particularly interesting at the level of the jejunum, part of the small intestine that plays an important role in the absorption of lipids and carbohydrates. Because of its location in the body, the jejunum is difficult to study, and its contribution to this metabolic disease was hitherto poorly understood. During their study, the scientists were able to collect jejunal tissue samples from patients during surgery to reduce their obesity and associated diseases (gastric bypass). These samples from 185 severely obese patients were compared with jejunal samples from 33 lean individuals undergoing digestive surgery for other reasons.

The research teams coordinated by Edith Brot-Laroche and Karine Clément observed a state of chronic inflammation affecting the small intestine in the obese patients, and colonization of the jejunal epithelium by T lymphocytes whose density increased in proportion to the degree of obesity. These immune cells release cytokines that inhibit the insulin sensitivity of absorbent intestinal epithelial cells. Because the action of insulin regulates nutrient absorption and glycemia, this immune phenomenon thus contributes to worsening the clinical status of these patients.

Further clinical studies also demonstrated that in obese patients, an increase in the intestinal density of T lymphocytes is probably linked to complications associated with obesity, such as liver disease (NASH) and dyslipidemia.

The results of this study also showed that the folds in the intestinal mucosa of the patients, or villi, were longer than those found in lean subjects.. This means that the surface of exchange in the small intestine is increased by 250% (equivalent to two tennis courts) and that these patients absorb more nutrients. This phenomenon, due to a reduction in apoptosis - a cell death mechanism - also reinforces the inflammatory action of the immune system in this region, and aggravates the disease.

While insulin resistance in adipose, hepatic, pancreatic and muscle tissue had already been observed in obese patients, this work has highlighted the existence of similar mechanisms in the small intestine and opens the way towards the possibility of non-invasive therapeutic interventions that could reduce inflammation of the intestine and thus control obesity.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Weekly exercise may reduce chronic kidney disease risk in obese people with type 2 diabetes